BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

866 related articles for article (PubMed ID: 19691461)

  • 1. Varicella zoster virus: review of its management.
    Mustafa MB; Arduino PG; Porter SR
    J Oral Pathol Med; 2009 Oct; 38(9):673-88. PubMed ID: 19691461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of herpes zoster (shingles) and postherpetic neuralgia.
    Stankus SJ; Dlugopolski M; Packer D
    Am Fam Physician; 2000 Apr; 61(8):2437-44, 2447-8. PubMed ID: 10794584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Herpes zoster and post-herpetic neuralgia in older adults].
    Lang PO; Zarate-Lagunes M; Pautex S
    Rev Med Suisse; 2008 Nov; 4(178):2398-402, 2404. PubMed ID: 19051627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
    Balfour HH
    Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varicella zoster: an update on current treatment options and future perspectives.
    Kim SR; Khan F; Ramirez-Fort MK; Downing C; Tyring SK
    Expert Opin Pharmacother; 2014 Jan; 15(1):61-71. PubMed ID: 24289750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for varicella-zoster virus infections.
    Andrei G; Snoeck R
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella-zoster virus: atypical presentations and unusual complications.
    Gnann JW
    J Infect Dis; 2002 Oct; 186 Suppl 1():S91-8. PubMed ID: 12353193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiviral drug therapy of infections caused by Herpes simplex and Varicella Zoster viruses].
    Vogt M; Huss R; Wunderli W
    Schweiz Med Wochenschr; 1992 Apr; 122(16):569-75. PubMed ID: 1579862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Varicella-zoster virus infections. 1: Chickenpox and shingles. Treatment and prevention].
    Wassilew SW
    MMW Fortschr Med; 2006; Spec no.1():1-5; quiz 6. PubMed ID: 16872125
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of shingles by varicella zoster virus vaccination.
    Holodniy M
    Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M; Breuer J
    Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
    Leung TF; Chik KW; Li CK; Lai H; Shing MM; Chan PK; Lee V; Yuen PM
    Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella-zoster virus: prospects for control.
    Gershon AA
    Adv Pediatr Infect Dis; 1995; 10():93-124. PubMed ID: 7718215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Swiss recommendations for the management of varicella-zoster virus infections].
    Meylan P; Gerber S; Kempf W; Nadal D;
    Rev Med Suisse; 2007 Sep; 3(125):2116-22, 2124-9. PubMed ID: 17939531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic understanding and control of varicella-zoster virus infection.
    Asano Y
    Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.
    Snoeck R; Andrei G; De Clercq E
    Drugs; 1999 Feb; 57(2):187-206. PubMed ID: 10188760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella-zoster virus latency in human ganglia.
    Kennedy PG
    Rev Med Virol; 2002; 12(5):327-34. PubMed ID: 12211045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.